Metropolitan Life Insurance Company (MetLife)’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-198
| Closed | -$14.2K | – | 1640 |
|
|
2024
Q1 | $14.2K | Sell |
198
-40
| -17% | -$2.87K | ﹤0.01% | 2014 |
|
|
2023
Q4 | $47.2K | Hold |
238
| – | – | ﹤0.01% | 1478 |
|
|
2023
Q3 | $31.6K | Buy |
238
+39
| +20% | +$5.18K | ﹤0.01% | 1654 |
|
|
2023
Q2 | $29.7K | Hold |
199
| – | – | ﹤0.01% | 1721 |
|
|
2023
Q1 | $29.1K | Hold |
199
| – | – | ﹤0.01% | 1699 |
|
|
2022
Q4 | $31.4K | Hold |
199
| – | – | ﹤0.01% | 1762 |
|
|
2022
Q3 | $38.2K | Hold |
199
| – | – | ﹤0.01% | 1636 |
|
|
2022
Q2 | $29K | Buy |
199
+42
| +27% | +$6.12K | ﹤0.01% | 1841 |
|
|
2022
Q1 | $27.6K | Sell |
157
-509
| -76% | -$89.6K | ﹤0.01% | 1932 |
|
|
2021
Q4 | $196K | Hold |
666
| – | – | ﹤0.01% | 2042 |
|
|
2021
Q3 | $165K | Hold |
666
| – | – | ﹤0.01% | 2215 |
|
|
2021
Q2 | $169K | Buy |
+666
| New | +$169K | ﹤0.01% | 2271 |
|
|
2020
Q4 | – | Sell |
-461
| Closed | -$119K | – | 2566 |
|
|
2020
Q3 | $119K | Hold |
461
| – | – | ﹤0.01% | 2119 |
|
|
2020
Q2 | $107K | Buy |
+461
| New | +$107K | ﹤0.01% | 2222 |
|